Last update 29 Nov 2024
SYH-2039
Last update 29 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms SYH2039 |
Target |
Mechanism Mat2A inhibitors(S-adenosylmethionine synthase isoform type-2 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with SYH-2039A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of SYH2039 Tablets in Adults With Advanced Solid Tumors
评价SYH2039片在晚期恶性肿瘤参与者中的安全性、耐受性、药代动力学特征以及初步抗肿瘤活性的I期临床试验
[Translation] A Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary anti-tumor activity of SYH2039 tablets in participants with advanced malignant tumors
100 Clinical Results associated with SYH-2039
Login to view more data
100 Translational Medicine associated with SYH-2039
Login to view more data
100 Patents (Medical) associated with SYH-2039
Login to view more data
100 Deals associated with SYH-2039
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | - | 21 Sep 2024 | |
| Methylthioadenosine phosphorylase deletion cancer | Phase 1 | - | 21 Sep 2024 | |
| Advanced cancer | Phase 1 | CN | 18 Jul 2024 | |
| Bladder Cancer | Preclinical | CN | - | |
| Gastrooesophageal junction cancer | Preclinical | CN | - | |
| Glioma | Preclinical | CN | - | |
| Non-Small Cell Lung Cancer | Preclinical | CN | - | |
| Pancreatic Cancer | Preclinical | CN | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free